(Total Views: 102)
Posted On: 08/30/2021 10:35:48 AM
Post# of 74550

$PSTX News Article - Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application for P-BCMA-ALLO1, an Allogeneic CAR-T Candidate for Relapsed/Refractory Multiple Myeloma https://marketwirenews.com/news-releases/pose...72517.html


My Twitter: WhyteStocks